Landfar Bio-medicine Co., Ltd reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 104.76 million compared to CNY 156.4 million a year ago. Revenue was CNY 104.76 million compared to CNY 156.4 million a year ago.

Net income was CNY 0.486718 million compared to CNY 0.540721 million a year ago. Basic earnings per share from continuing operations was CNY 0.0016 compared to CNY 0.0017 a year ago. Diluted earnings per share from continuing operations was CNY 0.0016 compared to CNY 0.0017 a year ago.